Awards
The Grifols Scientific Awards highlight our long-standing commitment to the scientific community. These recognitions promote and distinguish research in areas related to our core business.
Since our origins in 1909, Grifols has helped shape industry standards in the plasma-derived medicines sector. At the beginning of 1950, Dr. Josep Antoni Grifols i Lucas developed the plasmapheresis technique, which entails the process of extracting human plasma while simultaneously re-injecting the red blood cells back into the donor.
The plasmapheresis technique was quickly embraced by the global medical community and today remains one of the most frequently used plasma extraction techniques in blood banks and hospitals worldwide.
Today, we continue to innovate and at the same time support the development of the scientific community and its research efforts worldwide.
The Grifols Scientific Awards highlight our long-standing commitment to the scientific community. These recognitions promote and distinguish research in areas related to our core business.
Is a periodic award focused on encouraging health care providers, hemophilia treatment centers, as well as hemophilia societies to submit proposals that would contribute to improving the care of hemophilia patients and their quality of life.
In 2020, we allocated €4 million to education and scientific awards, including:
INVESTIGATOR-SPONSORED RESEARCH PROGRAM
Promote and support research that broadens the body of scientific knowledge on plasma proteins.
MEDICAL EDUCATIONAL GRANTS
The Grifols North America Medical Education Grants support independent medical education activities to advance the professional development of healthcare providers.
GRIFOLS CHAIR FOR THE STUDY OF CIRRHOSIS
In 2015, Grifols established The Grifols Chair for the Study of Cirrhosis, an initiative with a global reach aimed at generating research and education on liver diseases, particularly cirrhosis.
SCIENTIFIC PUBLICATIONS
We also promote the generation of knowledge internally. The work of Grifols' scientists and researchers has featured prominently in a number of prestigious publications.
J.R. Ferrándiz HOSPITAL PHARMACY AWARD
Innovation Award in the field of Hospital Pharmacy in Spain and Latin America.
Click here to learn more about the award (Spanish version)
Grifols is applying its deep knowledge of plasma to drive breakthrough therapeutic developments and solutions to treat patients.
Grifols researches, develops, produces and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare and highly prevalent diseases.
Grifols, we are people helping people. Each of us contributes to fulfill our mission of improving people's health and well-being around the world.